Penumbra, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 2, 2023

Penumbra, Inc. (NYSE: PEN) has announced a conference call to discuss its financial results for the first quarter of 2023.

Rhea-AI Summary

Penumbra, Inc. (NYSE: PEN) has announced a conference call to discuss its financial results for the first quarter of 2023. The call is scheduled for May 2, 2023, at 4:30 PM Eastern Time, following the release of the financial results after market close. Investors can access the conference call by dialing (888) 330-2443 or via a live webcast on Penumbra's website. The company is focused on innovative therapies and operates in more than 100 countries, addressing significant unmet medical needs.

Argus Session date unavailable

+0.62% session move Open Argus

Details

News Market Reaction – PEN

The recorded move for PEN in the trading session of this news was +0.62%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ALAMEDA, Calif., April 4, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023 at 4:30 PM Eastern Time. A press release with first quarter 2023 financial results will be issued after market close that day.

Webcast & Conference Call Information  
The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.

About Penumbra  
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.

Investor Relations

Penumbra, Inc.  
510-995-2461  
investors@penumbrainc.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-first-quarter-2023-earnings-release-and-conference-call-for-may-2-2023-301783992.html

SOURCE Penumbra, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Penumbra's first quarter 2023 earnings release?

Penumbra's first quarter 2023 earnings release is scheduled for May 2, 2023.

What time is Penumbra's conference call for Q1 2023 earnings?

The conference call for Penumbra's Q1 2023 earnings will start at 4:30 PM Eastern Time.

How can I access the Penumbra earnings conference call?

The conference call can be accessed by dialing (888) 330-2443 or via a live webcast on Penumbra's website.

Where can I find more information about Penumbra's financial results?

More information about Penumbra's financial results will be available on their website after the earnings release on May 2, 2023.